Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure
…, J Wesseling, CE Loo, M Schot, CA Drukker… - Annals of …, 2015 - journals.lww.com
Objective: The MARI procedure [marking the axillary lymph node with radioactive iodine (125
I) seeds] is a new minimal invasive method to assess the pathological response of nodal …
I) seeds] is a new minimal invasive method to assess the pathological response of nodal …
A prospective evaluation of a breast cancer prognosis signature in the observational RASTER study
CA Drukker, JM Bueno‐de‐Mesquita… - … journal of cancer, 2013 - Wiley Online Library
The 70‐gene signature (MammaPrint™) has been developed on retrospective series of
breast cancer patients to predict the risk of breast cancer distant metastases. The microarRAy‐…
breast cancer patients to predict the risk of breast cancer distant metastases. The microarRAy‐…
Guiding breast-conserving surgery in patients after neoadjuvant systemic therapy for breast cancer: a comparison of radioactive seed localization with the ROLL …
M Donker, CA Drukker, RA Valdés Olmos… - Annals of surgical …, 2013 - Springer
Background Radioguided occult lesion localization (ROLL) with technetium-99 m colloid (ROLL-
99m Tc) is commonly used to perform breast-conserving surgery in patients with …
99m Tc) is commonly used to perform breast-conserving surgery in patients with …
Outcome of patients with an ultralow-risk 70-gene signature in the MINDACT trial
JMN Lopes Cardozo, CA Drukker… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE Patients with 70-gene signature ultralow-risk breast cancers have shown excellent
survival in historic cohorts, including randomized trials. The ultralow-risk subgroup was …
survival in historic cohorts, including randomized trials. The ultralow-risk subgroup was …
[HTML][HTML] Mammographic screening detects low-risk tumor biology breast cancers
CA Drukker, MK Schmidt, EJT Rutgers… - Breast cancer research …, 2014 - Springer
Overdiagnosis of breast cancer, ie the detection of slow-growing tumors that would never have
caused symptoms or death, became more prevalent with the implementation of population…
caused symptoms or death, became more prevalent with the implementation of population…
Associations of a breast cancer polygenic risk score with tumor characteristics and survival
PURPOSE A polygenic risk score (PRS) consisting of 313 common genetic variants (PRS313)
is associated with risk of breast cancer and contralateral breast cancer. This study aimed …
is associated with risk of breast cancer and contralateral breast cancer. This study aimed …
[HTML][HTML] A breast cancer gene signature for indolent disease
LJMJ Delahaye, CA Drukker, C Dreezen… - Breast Cancer Research …, 2017 - Springer
Purpose Early-stage hormone-receptor positive breast cancer is treated with endocrine
therapy and the recommended duration of these treatments has increased over time. While …
therapy and the recommended duration of these treatments has increased over time. While …
[HTML][HTML] Outcome without any adjuvant systemic treatment in stage I ER+/HER2− breast cancer patients included in the MINDACT trial
JMNL Cardozo, D Byng, CA Drukker, MK Schmidt… - Annals of …, 2022 - Elsevier
Background Adjuvant systemic treatments (AST) reduce mortality, but have associated short-
and long-term toxicities. Careful selection of patients likely to benefit from AST is needed. …
and long-term toxicities. Careful selection of patients likely to benefit from AST is needed. …
[HTML][HTML] Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms
CA Drukker, MV Nijenhuis… - Breast cancer research …, 2014 - Springer
Clinical guidelines for breast cancer treatment differ in their selection of patients at a high
risk of recurrence who are eligible to receive adjuvant systemic treatment (AST). The 70-gene …
risk of recurrence who are eligible to receive adjuvant systemic treatment (AST). The 70-gene …
[HTML][HTML] Long-term oncological outcomes of papillary thyroid cancer and follicular thyroid cancer in children: A nationwide population-based study
…, AMJ Kuijpers, AF Engelsman, CA Drukker… - Frontiers in …, 2022 - frontiersin.org
Introduction Pediatric thyroid carcinoma is a rare malignancy and data on long-term oncological
outcomes are sparse. The aim of this study was to describe the long-term oncological …
outcomes are sparse. The aim of this study was to describe the long-term oncological …
